Literature DB >> 1739473

Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study.

J M Gardin1, N D Wong, W Bommer, H S Klopfenstein, V E Smith, B Tabatznik, D Siscovick, S Lobodzinski, H Anton-Culver, T A Manolio.   

Abstract

The Framingham study has shown by M-mode echocardiography that left ventricular hypertrophy is a powerful, independent predictor for the development of coronary heart disease and that increased left atrial dimension has been associated with an increased risk of stroke. No previous population-based study has evaluated the risk factor correlates and predictive value for coronary heart disease and stroke of two-dimensional and Doppler, as well as M-mode, echocardiography. The Cardiovascular Health Study is a multi-year prospective epidemiologic study of 5201 men and women older than 65 recruited from four geographic sites in the United States. The main objectives of incorporating echocardiography were to determine whether echocardiographic indices, or changes in these indices, are (1) correlated with traditional risk factors for coronary heart disease and stroke; and (2) independent predictors of morbidity and mortality for coronary heart disease and stroke. Echocardiographic measurements of interest include those related to global and segmental left ventricular systolic and diastolic structure and function and left atrial size. For each subject, a baseline echocardiogram was recorded in super-VHS tape using a standard protocol and equipment. All studies were sent to a reading center where images were digitized and measurements were made using customized computer algorithms. Calculated data and images were stored on optical disks to facilitate retrieval and future comparisons in longitudinal studies. A second echocardiogram is scheduled in year 7, with a goal of determining whether changes in cardiac anatomy or function over a 5-year period are important predictors of morbidity or mortality from coronary heart disease and stroke. Quality control measures included standardized training of echocardiography technicians and readers, technician observation by a trained echocardiographer, periodic blind duplicate readings with reader review sessions, phantom studies, and quality control adults.

Entities:  

Mesh:

Year:  1992        PMID: 1739473     DOI: 10.1016/s0894-7317(14)80105-3

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  74 in total

1.  Left ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death?

Authors:  Christopher R deFilippi; Robert H Christenson; Willem J Kop; John S Gottdiener; Min Zhan; Stephen L Seliger
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.

Authors:  Khiet Hoang; Yanglu Zhao; Julius M Gardin; Mercedes Carnethon; Ken Mukamal; David Yanez; Nathan D Wong
Journal:  JACC Cardiovasc Imaging       Date:  2015-08-26

3.  Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study.

Authors:  Jason H Y Wu; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Frank M Sacks; Eric B Rimm; Susan R Heckbert; David S Siscovick; Dariush Mozaffarian
Journal:  Circulation       Date:  2012-01-26       Impact factor: 29.690

4.  Association between brachial artery reactivity and cardiovascular disease status in an elderly cohort: the cardiovascular health study.

Authors:  Joseph Yeboah; Kim Sutton-Tyrrell; Mary Ann Mcburnie; Gregory L Burke; David M Herrington; John R Crouse
Journal:  Atherosclerosis       Date:  2007-08-21       Impact factor: 5.162

5.  The clinical utility of normal findings on noninvasive cardiac assessment in the prediction of atrial fibrillation.

Authors:  Sanjay Venkatesh; Wesley T O'Neal; Stephen T Broughton; Amit J Shah; Elsayed Z Soliman
Journal:  Clin Cardiol       Date:  2017-02-13       Impact factor: 2.882

6.  N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study.

Authors:  Kristen K Patton; Nona Sotoodehnia; Christopher DeFilippi; David S Siscovick; John S Gottdiener; Richard A Kronmal
Journal:  Heart Rhythm       Date:  2010-10-30       Impact factor: 6.343

7.  Racial differences in the incidence of and risk factors for atrial fibrillation in older adults: the cardiovascular health study.

Authors:  Paul N Jensen; Evan L Thacker; Sascha Dublin; Bruce M Psaty; Susan R Heckbert
Journal:  J Am Geriatr Soc       Date:  2013-01-15       Impact factor: 5.562

8.  Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study.

Authors:  Amil M Shah; Susan Cheng; Hicham Skali; Justina Wu; Judy R Mangion; Dalane Kitzman; Kunihiro Matsushita; Suma Konety; Kenneth R Butler; Ervin R Fox; Nakela Cook; Hanyu Ni; Josef Coresh; Thomas H Mosley; Gerardo Heiss; Aaron R Folsom; Scott D Solomon
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-08       Impact factor: 7.792

9.  Relationship of bone mineral density with valvular and annular calcification in community-dwelling older people: The Cardiovascular Health Study.

Authors:  Daniele Massera; Shuo Xu; Traci M Bartz; Anna E Bortnick; Joachim H Ix; Michel Chonchol; David S Owens; Eddy Barasch; Julius M Gardin; John S Gottdiener; John R Robbins; David S Siscovick; Jorge R Kizer
Journal:  Arch Osteoporos       Date:  2017-05-30       Impact factor: 2.617

10.  Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study.

Authors:  Hassan A Chami; Richard B Devereux; John S Gottdiener; Reena Mehra; Mary J Roman; Emelia J Benjamin; Daniel J Gottlieb
Journal:  Circulation       Date:  2008-05-05       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.